title: Detection of Influenza and Other Respiratory Viruses Carried Out in the Influenza Project - Monitoring Vaccine Effectiveness (I-MOVE).
abstract: The project Influenza Vaccine Effectiveness-Monitoring (I-MOVE) is part of the European research carried out by the ECDC (European Center for Disease Prevention and Control), aimed at monitoring the effectiveness of vaccination in Europe during the growing incidence of flu and influenza-like illnesses in the coming epidemic seasons. Laboratory studies using molecular RT-PCR biology methods for detection of genetic material of influenza virus and other respiratory viruses were performed by Voivodeship Sanitary-Epidemiological Stations in Poland. The validation of the results of swabs taken from the nose and throat were carried out in the Department of Influenza Research, National Influenza Center in Warsaw. The study involved 210 samples from patients across Poland. Positive results were recorded for 72.4 % of the samples; influenza virus type A was detected in 43 and type B in 38 cases, whereas in 71 cases other respiratory viruses were detected, which included Human parainfluenza virus type 1-4; Human respiratory syncytial virus type A and B; Human coronavirus 229E/NL63, OC43; Human rhinovirus type A, B, and C; Human enterovirus; and Human adenovirus. The results show that although influenza viruses predominated in the 2010/2011 season in Poland, other flu-like viruses also abounded.
authors.affiliation: Department of Influenza Research, National Influenza Center, National Institute of Public Health-National Institute of Hygiene, 24 Chocimska St., 00-791, Warsaw, Poland, kaj12@poczta.fm.
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Woźniak-Kosek
mesh_terms: D062665:Epidemiological Monitoring; D005062:European Union; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control*; D009975:Orthomyxoviridae / Q000302:isolation & purification*; D011044:Poland / Q000453:epidemiology; D012141:Respiratory Tract Infections / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology*; D018108:Respirovirus / Q000302:isolation & purification; D012229:Rhinovirus / Q000302:isolation & purification; D014611:Vaccination / Q000379:methods*; D014765:Viral Vaccines / Q000008:administration & dosage
chemical_list: D007252:Influenza Vaccines; D014765:Viral Vaccines